GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyorin Pharmaceutical Co Ltd (TSE:4569) » Definitions » Median PS Value

Kyorin Pharmaceutical Co (TSE:4569) Median PS Value : 円2,665.71 (As of May. 22, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Kyorin Pharmaceutical Co Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Kyorin Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円2089.275. Kyorin Pharmaceutical Co's 10-Year median PS Ratio is 1.2759. Therefore, the Median PS Value for today is 円2,665.71.

As of today (2024-05-22), Kyorin Pharmaceutical Co's share price is 円1714.00. Kyorin Pharmaceutical Co's Median PS Value is 円2,665.71. Therefore, Kyorin Pharmaceutical Co's Price to Median PS Value for today is 0.64.

The historical rank and industry rank for Kyorin Pharmaceutical Co's Median PS Value or its related term are showing as below:

TSE:4569' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.64   Med: 0.73   Max: 1.12
Current: 0.64

During the past 13 years, the highest Price to Median PS Value of Kyorin Pharmaceutical Co was 1.12. The lowest was 0.64. And the median was 0.73.

TSE:4569's Price-to-Median-PS-Value is ranked better than
70.81% of 507 companies
in the Drug Manufacturers industry
Industry Median: 0.84 vs TSE:4569: 0.64

Kyorin Pharmaceutical Co Median PS Value Historical Data

The historical data trend for Kyorin Pharmaceutical Co's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyorin Pharmaceutical Co Median PS Value Chart

Kyorin Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,451.91 2,621.71 2,452.51 2,514.56 2,660.11

Kyorin Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,580.97 2,660.11 2,689.60 2,714.45 2,665.71

Competitive Comparison of Kyorin Pharmaceutical Co's Median PS Value

For the Drug Manufacturers - Specialty & Generic subindustry, Kyorin Pharmaceutical Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kyorin Pharmaceutical Co's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyorin Pharmaceutical Co's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Kyorin Pharmaceutical Co's Price-to-Median-PS-Value falls into.



Kyorin Pharmaceutical Co Median PS Value Calculation

Kyorin Pharmaceutical Co's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=2089.275*1.2759
=2,665.71

10-Year Median PS Ratio is 1.2759.
Kyorin Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2089.275.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kyorin Pharmaceutical Co  (TSE:4569) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Kyorin Pharmaceutical Co's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=1714.00/2,665.71
=0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kyorin Pharmaceutical Co Median PS Value Related Terms

Thank you for viewing the detailed overview of Kyorin Pharmaceutical Co's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Kyorin Pharmaceutical Co (TSE:4569) Business Description

Traded in Other Exchanges
N/A
Address
6, Kanda Surugadai 4-chome, Chiyoda-ku, Tokyo, JPN, 101-8311
Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.

Kyorin Pharmaceutical Co (TSE:4569) Headlines

No Headlines